Theophylline treatment may adversely affect the anoxia-induced erythropoietic response without suppressing erythropoietin production.

Abstract:

OBJECTIVE:To investigate the influence of theophylline on erythropoiesis in chronic obstructive pulmonary disease (COPD) and explore the potential underlying mechanisms. METHODS:We evaluated the haematological parameters and erythropoietin (EPO) values in 38 COPD patients, 18 of which had been treated with theophylline (8 mg/kg daily) for at least 1 year, and the other 20 had never received this drug; 38 sex- and age-matched healthy volunteers served as controls. We further studied the development of BFU-E (bursts forming units of erythrocyte precursors) -derived colonies in semisolid methylcellulose cultures in blood samples from 7 patients randomly selected from both groups. In addition, we studied the effects of theophylline on the erythroid cell development by adding this agent to erythroid cell cultures from 6 healthy volunteers at various concentrations. RESULTS:Haemoglobin values were found to be significantly lower in COPD patients treated with theophylline than in those untreated ( P<0.05). Both groups of patients exhibited significantly higher haemoglobin values than normal subjects ( P<0.01 and P<0.001 for treated and untreated patients, respectively). Serum EPO levels did not differ among the three studied groups. Unlike untreated patients and controls, the serum of the theophylline-treated patients produced a significant growth inhibition of erythroid bursts ( P<0.05); the in vitro use of theophylline showed a concentration-dependent inhibition ( P<0.001). CONCLUSION:Our findings confirm the decrease of red cell production, which occurs following administration of theophylline, exclude the possibility of decreased EPO synthesis and suggest a direct inhibitory action of theophylline on erythropoiesis.

journal_name

Eur J Clin Pharmacol

authors

Tsantes AE,Tassiopoulos ST,Papadhimitriou SI,Bonovas S,Poulakis N,Vlachou A,Filioussi K,Loukopoulos D

doi

10.1007/s00228-003-0640-0

subject

Has Abstract

pub_date

2003-09-01 00:00:00

pages

379-83

issue

5-6

eissn

0031-6970

issn

1432-1041

journal_volume

59

pub_type

杂志文章
  • Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma.

    abstract:PURPOSE:Panobinostat, a potent pan-deacetylase inhibitor, improved progression-free survival (PFS) in patients with relapsed and refractory multiple myeloma when combined with bortezomib and dexamethasone in a phase 3 trial, PANORAMA-1. This study aims to explore exposure-response relationship for panobinostat in this ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s00228-015-1967-z

    authors: Mu S,Kuroda Y,Shibayama H,Hino M,Tajima T,Corrado C,Lin R,Waldron E,Binlich F,Suzuki K

    更新日期:2016-02-01 00:00:00

  • Adverse drug reactions: analysis of spontaneous reporting system in Europe in 2007-2009.

    abstract:PURPOSE:Spontaneous reporting systems in European countries are crucial for collecting adverse drug reaction (ADR) reports. The aim of this study was to evaluate reporting activity among countries and their strategy to increase the number of reports. We also established the best measure for assessment quantity of repor...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-012-1219-4

    authors: Srba J,Descikova V,Vlcek J

    更新日期:2012-07-01 00:00:00

  • Hydralazine-induced lupus: is there a toxic metabolic pathway?

    abstract::The metabolism of hydralazine in a group of slow acetylator patients with the drug-induced lupus syndrome was compared with the metabolism in asymptomatic control subjects. There were no toxicologically significant difference in metabolite excretion between the groups which reached statistical significance, although t...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00556891

    authors: Timbrell JA,Facchini V,Harland SJ,Mansilla-Tinoco R

    更新日期:1984-01-01 00:00:00

  • Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period.

    abstract:OBJECTIVE:The efficacy of beta-adrenergic blocking agents and acetylsalicylic acid in the secondary prevention of myocardial infarction has been well recognized since the beginning of the 1980s. In a previous paper, however, we reported a lower than expected use of these drugs during the period 1982 1988. In 1989 the r...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280050446

    authors: Martínez M,Agustí A,Arnau JM,Vidal X,Laporte JR

    更新日期:1998-05-01 00:00:00

  • Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.

    abstract:PURPOSE:The purpose of this study was to investigate the interactions of itraconazole (ITCZ) with orally administered calcineurin inhibitors (CNIs) in Japanese allogeneic hematopoietic stem cell transplant (HSCT) recipients. METHODS:Sixteen HSCT patients (8 patients each receiving tacrolimus or cyclosporine) were enro...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-013-1471-2

    authors: Nara M,Takahashi N,Miura M,Niioka T,Kagaya H,Fujishima N,Saitoh H,Kameoka Y,Tagawa H,Hirokawa M,Sawada K

    更新日期:2013-06-01 00:00:00

  • Trends in opioid analgesics consumption, Israel, 2000-2008.

    abstract:OBJECTIVE:To describe trends in opioid consumption in Israel (morphine, methadone, oxycodone, pethidine, fentanyl, buprenorphine, codeine, and dextropropoxyphene) over the 9 years, 2000-2008, and to explore explanations for changes in consumption, in amounts and the pattern. METHODS:Data for the 2000-2008 period (all ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-010-0932-0

    authors: Ponizovsky AM,Marom E,Zeldin A,Cherny NI

    更新日期:2011-02-01 00:00:00

  • Acute effects of trimetazidine evaluated by exercise testing.

    abstract::A single dose of 60 mg trimetazidine (the normal daily dose) improved exercise capacity in angina pectoris, as reflected by an increase in the duration of exercise, total work performed, and improvement in ECG signs of ischaemia. All these effects occurred without any detectable chronotropic or vasomotor effect. The i...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00544569

    authors: Sellier P,Audouin P,Payen B,Corona P,Duong TC,Ourbak P

    更新日期:1987-01-01 00:00:00

  • Captopril does not interact with the pharmacodynamics and pharmacokinetics of digitoxin in healthy man.

    abstract::The chronic oral administration of 0.07 mg digitoxin o.d. for up to 58 days to 12 healthy volunteers caused a small drop in mean heart rate HR (95% CI: -7.9 to -1.6 beats.min-1), in mean diastolic blood pressure (95% CI: -8.3 to -0.4 mmHg), shortening of the QTc-interval (95% CI: -42 to -19 ms), shortening of the HR-c...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF02220626

    authors: de Mey C,Elich D,Schroeter V,Butzer R,Belz GG

    更新日期:1992-01-01 00:00:00

  • Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease.

    abstract::Plasma aspirin, salicylate and salicyluric acid concentrations were monitored in young, elderly and alcoholic subjects after ingestion of a single 1.2 g dose of soluble aspirin. The plasma aspirin, salicylate and unbound salicylate concentration-time profiles varied considerably between individual subjects. Most of th...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00543800

    authors: Roberts MS,Rumble RH,Wanwimolruk S,Thomas D,Brooks PM

    更新日期:1983-01-01 00:00:00

  • A comparison of the pharmacokinetics of mefloquine in healthy Thai volunteers and in Thai patients with falciparum malaria.

    abstract::We have studied the kinetics of a single oral dose of mefloquine (750 mg) in 12 Thai patients with falciparum malaria and have compared the results with those of a previous study in 12 healthy Thai volunteers. All the patients responded to treatment with a mean parasite clearance time of 66.6 h and a mean fever cleara...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00637607

    authors: Karbwang J,Back DJ,Bunnag D,Breckenridge AM

    更新日期:1988-01-01 00:00:00

  • Effect of a single-dose rifampin on the pharmacokinetics of pitavastatin in healthy volunteers.

    abstract:PURPOSE:As an inhibitor of HMG-CoA reductase that catalyses the first step of cholesterol synthesis, pitavastatin undergoes little hepatic metabolism; however, it is a substrate of uptake and efflux transporters. Since pitavastatin is potentially co-administered with agents that affect transporter activities, the pharm...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s00228-013-1554-0

    authors: Chen Y,Zhang W,Huang WH,Tan ZR,Wang YC,Huang X,Zhou HH

    更新日期:2013-11-01 00:00:00

  • Gastric inhibitory effects of CM57755. A new histamine H2 receptor antagonist.

    abstract::The gastric inhibitory effects of CM57755, a new histamine H2 receptor antagonist, have been compared in ten healthy male volunteers with the actions of an equal dose of cimetidine and with placebo. The inhibitory effect of CM57755 was virtually identical with, and not significantly different from the effects of cimet...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00614192

    authors: Wilson JA,Johnston D,Penston J,Wormsley KG

    更新日期:1986-01-01 00:00:00

  • Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction.

    abstract:PURPOSE:We assessed possible drug interactions of tramadol given concomitantly with the potent CYP2B6 inhibitor ticlopidine, alone or together with the potent CYP3A4 and P-glycoprotein inhibitor itraconazole. METHODS:In a randomized, placebo-controlled cross-over study, 12 healthy subjects ingested 50 mg of tramadol a...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s00228-012-1433-0

    authors: Hagelberg NM,Saarikoski T,Saari TI,Neuvonen M,Neuvonen PJ,Turpeinen M,Scheinin M,Laine K,Olkkola KT

    更新日期:2013-04-01 00:00:00

  • Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials.

    abstract:PURPOSE:To assess the efficacy of acetylleucine to improve or stop an attack of vertigo and dizziness (vertigo/dizziness). METHODS:Systematic review by 2 independent reviewers. Consultation of the Medline, Cochrane and ClinicalTrials.gov databases until September 2018. Keywords used: Acetylleucine, Tanganil®, Acetyl-D...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,meta分析

    doi:10.1007/s00228-018-02617-6

    authors: Vanderkam P,Blanchard C,Naudet F,Pouchain D,Vaillant Roussel H,Perault-Pochat MC,Jaafari N,Boussageon R

    更新日期:2019-05-01 00:00:00

  • The effect of acarbose on the pharmacokinetics of rosiglitazone.

    abstract:OBJECTIVES:To investigate whether treatment with acarbose alters the pharmacokinetics (PK) of coadministered rosiglitazone. METHODS:Sixteen healthy volunteers (24-59-years old) received a single 8-mg dose of rosiglitazone on day 1, followed by 7 days of repeat dosing with acarbose [100 mg three times daily (t.i.d.) wi...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s002280100275

    authors: Miller AK,Inglis AM,Culkin KT,Jorkasky DK,Freed MI

    更新日期:2001-05-01 00:00:00

  • Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects.

    abstract::The comparative enzyme inducing effects of rifabutin and the chemically related drug rifampicin have been investigated in 8 normal subjects. Rifampicin 600 mg daily for 7 days caused considerable shortening of the antipyrine half-life and a marked increase in antipyrine clearance, associated with an increased rate of ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00615223

    authors: Perucca E,Grimaldi R,Frigo GM,Sardi A,Mönig H,Ohnhaus EE

    更新日期:1988-01-01 00:00:00

  • Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.

    abstract:OBJECTIVE:This work aimed at building a population pharmacokinetic (PK) model for lamivudine (LMV), stavudine (STV) and zidovudine (ZDV), estimating their inter and intraindividual PK variability and investigating the influence of different covariates. METHODS:Population PK of LMV, STV and ZDV was separately evaluated...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1007/s00228-007-0337-x

    authors: Panhard X,Legrand M,Taburet AM,Diquet B,Goujard C,Mentré F,Cophar 1 - ANRS 102 Study Group.

    更新日期:2007-11-01 00:00:00

  • The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.

    abstract::This study investigates the acute haemodynamic effects of Quinapril (CI-906) a new non-sulphydryl angiotensin converting enzyme inhibitor in 15 patients with refractory congestive cardiac failure. There were 14 males and 1 female mean age 59.5 years. After administration of Quinapril there was a significant reduction ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00870978

    authors: Holt P,Najm J,Sowton E

    更新日期:1986-01-01 00:00:00

  • Haemodynamic effects of intravenous verapamil at rest and during exercise in subjectively healthy middle-aged men.

    abstract::Verapamil, 0.1 mg/kg body wt, was injected i.v. over 2 minutes in 8 subjectively healthy middle-aged men, followed by a continuous infusion of 0.007 mg/kg body wt per minute. Prior to the injection several of the subjects had raised pulmonary or systemic arterial pressures. At rest, the central pressures increased sli...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00562656

    authors: Atterhög JH,Ekelund LG

    更新日期:1975-06-13 00:00:00

  • Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension.

    abstract::The antihypertensive effect of a new vasodilator with betablocking properties (SK & F 92657) was investigated in 10 patients with mild to moderate essential hypertension. After a mean treatment period of 26,5 weeks (6,5-49 weeks) blood pressure was significantly reduced, from 168 +/- 22/106 +/- 6 mmHg to 144 +/- 19/94...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00605990

    authors: Lüscher T,Havelka J,Greminger P,Tuma J,Täuber M,Siegenthaler W,Vetter W

    更新日期:1982-01-01 00:00:00

  • Effect of posture and sleep on pharmacokinetics. I. Amoxycillin.

    abstract::The pharmacokinetics of amoxycillin in normal male volunteers was studied during the states of bedrest, sleep and ambulation. The absorption and disposition of amoxycillin in ambulatory subjects was found to be comparable to that reported previously by other workers. Serum amoxycillin concentrations were found to be s...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00561587

    authors: Roberts MS,Denton MJ

    更新日期:1980-08-01 00:00:00

  • Effect of quinidine on digoxin bioavailability.

    abstract::To evaluate the possible effect of quinidine on digoxin bioavailability, the steady state digoxin kinetics was examined with and without concomitant quinidine therapy, in 7 cardiac patients after simultaneous administration of oral digoxin and intravenous [3H]-digoxin. In the presence of quinidine, the absorption rate...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00613925

    authors: Pedersen KE,Christiansen BD,Klitgaard NA,Nielsen-Kudsk F

    更新日期:1983-01-01 00:00:00

  • Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status.

    abstract::The pharmacokinetics of i.v. chloramphenicol succinate and oral chloramphenicol palmitate were studied in Ethiopian children with different nutritional states. In children with kwashiorkor the plasma clearance of chloramphenicol was significantly lower than in children of normal weight (4.16 ml/min/kg versus 7.53 ml/m...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00607094

    authors: Eriksson M,Paalzow L,Bolme P,Mariam TW

    更新日期:1983-01-01 00:00:00

  • CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy.

    abstract:PURPOSE:The purpose of this study is to investigate the effect of two of the most important functional CYP1A2 variations -3860G > A and -163C > A on carbamazepine pharmacokinetics in Serbian pediatric epileptic patients. METHODS:The study involved 40 Serbian pediatric epileptic patients on steady-state carbamazepine t...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-015-2006-9

    authors: Djordjevic N,Milovanovic DD,Radovanovic M,Radosavljevic I,Obradovic S,Jakovljevic M,Milovanovic D,Milovanovic JR,Jankovic S

    更新日期:2016-04-01 00:00:00

  • Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

    abstract:PURPOSE:Drug-induced immune thrombocytopaenia is a rare, serious condition that can be triggered by numerous medications. To characterize the spectrum of drugs associated with immune thrombocytopaenia (ITP) in the Berlin Case-Control Surveillance Study (FAKOS). METHODS:Adult hospitalized patients with new onset idiopa...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s00228-011-1184-3

    authors: Garbe E,Andersohn F,Bronder E,Salama A,Klimpel A,Thomae M,Schrezenmeier H,Hildebrandt M,Späth-Schwalbe E,Grüneisen A,Meyer O,Kurtal H

    更新日期:2012-05-01 00:00:00

  • Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers.

    abstract:INTRODUCTION:Deoxycytidine kinase (DCK) is the rate-limiting enzyme of the intracellular phosphorylation of nucleoside anticancer drugs, including gemcitabine and beta-arabinofuranosylcytosine, to their active triphosphates. This study was performed to assess the occurrence and frequency of DCK polymorphisms in a predo...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-006-0162-7

    authors: Joerger M,Bosch TM,Doodeman VD,Beijnen JH,Smits PH,Schellens JH

    更新日期:2006-08-01 00:00:00

  • Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man.

    abstract:OBJECTIVE:To investigate the usefulness of the 3-hydroxylation of quinine as a biomarker reaction for the activity of CYP3A4 in man and to study the interindividual variation in the metabolic ratio (MR), i.e. quinine/3-hydroxyquinine. METHODS:Data from a previous study (A) was used for determination of the MR of quini...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s00228-003-0575-5

    authors: Mirghani RA,Ericsson O,Tybring G,Gustafsson LL,Bertilsson L

    更新日期:2003-05-01 00:00:00

  • A preliminary study of the pharmacodynamics and pharmacokinetics of a novel enkephalin analogue [Tyr-D.Arg-Gly-Phe (4NO2).Pro.NH2 (BW443C)] in healthy volunteers.

    abstract::We have studied 16 healthy men to evaluate preliminary pharmacodynamics and kinetics of BW443C given by i.v. infusions. Four volunteers received escalating doses at weekly intervals, starting at 0.1 microgram.kg-1 for 60 min and increasing to a maximum of 2.0 micrograms.kg-1.min-1 for 180 min. Subsequently 12 differen...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF01061420

    authors: Posner J,Dean K,Jeal S,Moody SG,Peck AW,Rutter G,Telekes A

    更新日期:1988-01-01 00:00:00

  • Slower onset of vasodilating action of brain natriuretic peptide (BNP) compared to atrial natriuretic peptide (ANP) in human forearm resistant vessels.

    abstract:PURPOSE:To investigate possible differences in the time course of vasodilating effects of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in humans. METHODS:We measured forearm blood flow (FBF) by strain gauge plethymography and cyclic GMP spillover during and after intra-arterial infusions of BNP...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-008-0516-4

    authors: Minami H,Yasu T,Tagawa T,Yamakawa K,Ueda S

    更新日期:2008-09-01 00:00:00

  • Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.

    abstract::Since little is known of the number and types of binding sites on alpha 1-acid glycoprotein (AAG) and because drug-drug protein binding interactions often fail to fit a simple model, a study of the effect of 9 known AAG binding drugs on lidocaine free fraction (LFF) was performed. Serum was obtained from 10 healthy ma...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF01037957

    authors: Goolkasian DL,Slaughter RL,Edwards DJ,Lalka D

    更新日期:1983-01-01 00:00:00